Astragaloside IV attenuates hypoxia-reoxygenation-induced endothelial senescence and vascular inflammation by modulating the NOTCH1/VCAM-1 axis.
Overview
Abstract
Objective: Alzheimer's disease (AD) progression involves cerebral microvascular endothelial cell senescence induced by brain hypoperfusion, which contributes to blood-brain barrier (BBB) dysfunction. While Notch1 signaling is known to exacerbate endothelial senescence and neuroinflammation via vascular cell adhesion molecule-1 (VCAM-1), the mechanism by which it mediates hypoxia-induced endothelial aging in AD remains unclear. Furthermore, although Astragaloside IV (AS-IV) has been shown to alleviate cerebral hypoperfusion in AD, whether it acts by directly modulating the Notch1/
Methods: Transcriptomic analysis of AD patient data and network pharmacology identified NOTCH1 as a key target. Molecular docking and 100-ns molecular dynamics simulations (using Desmond) characterized AS-IV–Notch1 interactions. Human brain microvascular endothelial cells (HBMECs) were subjected to hypoxia-reoxygenation (HR) to model AD-associated hypoperfusion. Cells were treated with AS-IV (25, 50, or 100 μM) or N-acetylcysteine (NAC) as a positive antioxidant control. Notch1 signaling was experimentally modulated using a recombinant decoy receptor to simulate signaling blockade, creating a contrast with HR-induced overactivation. Assessments included CCK-8 assays, MDA and ROS detection, qPCR, and Western blotting.
Results: NOTCH1 expression was upregulated in AD patients. Molecular docking and dynamics simulations predicted a stable binding mode between AS-IV and Notch1. HR exposure significantly increased oxidative stress and upregulated senescence markers (p16, p21, and p53), proinflammatory senescence-associated secretory phenotype (SASP) factors (IL-6, IL-1β, and TNF-α), and Notch1/
Conclusion: AS-IV alleviates HR-induced endothelial senescence by modulating the Notch1/
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE122063, at NCBI GEO; found in the text, “Transcriptomics analysis”
Data availability statement
The original contributions presented in the study are included in the article/
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, pages, dates, 3 authors, 6 keywords, 37 references.
Cite
This paper
Huang, D., Zhou, R., & Ling, J. (2026). Astragaloside IV attenuates hypoxia-reoxygenation-in
BibTeX
@article{huang2026astrag
author = {Huang, Dehui and Zhou, Rongjing and Ling, Jun},
title = {{Astragaloside IV attenuates hypoxia-reoxygenation-in
journal = {Frontiers in aging neuroscience},
year = {2026},
month = aug,
volume = {18},
pages = {1855522},
publisher = {Frontiers Media SA},
issn = {1663-4365},
doi = {10.3389/
url = {https://
pmid = {42729321},
pmcid = {PMC13561900}
}
RIS
TY - JOUR
AU - Huang, Dehui
AU - Zhou, Rongjing
AU - Ling, Jun
TI - Astragaloside IV attenuates hypoxia-reoxygenation-in
T2 - Frontiers in aging neuroscience
J2 - Front Aging Neurosci
PY - 2026
DA - 2026/
VL - 18
SP - 1855522
SN - 1663-4365
PB - Frontiers Media SA
DO - 10.3389/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.3389/
"type": "article-journal",
"title": "Astragaloside IV attenuates hypoxia-reoxygenation-in
"container-title": "Frontiers in aging neuroscience",
"author": [
{
"family": "Huang",
"given": "Dehui"
},
{
"family": "Zhou",
"given": "Rongjing"
},
{
"family": "Ling",
"given": "Jun"
}
],
"container-title-short":
"volume": "18",
"page": "1855522",
"DOI": "10.3389/
"PMID": "42729321",
"PMCID": "PMC13561900",
"ISSN": "1663-4365",
"publisher": "Frontiers Media SA",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
8,
28
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.3389/fgene.2022.1038585
- Transcriptome analysis reveals potential marker genes for diagnosis of Alzheimer's disease and vascular dementia.Journal: Frontiers in geneticsIn common: NCBI GEO GSE122063, Alzheimer's / dementia, 1 reference
- [2] doi:10.1038/s41598-026-40339-3
- ELK1 suppressed the progression of vascular dementia via modulating mTOR/
CREB/ YAP/ TFEB signaling induced ferroptosis in hippocampal cells. Journal: Scientific reportsIn common: NCBI GEO GSE122063, Alzheimer's / dementia, cellular / molecular, 1 reference - [3] doi:10.1371/journal.pone.0332987
- Mitochondrial dysfunction-related metabolite methylmalonic acid is associated with decreased cognitive performance.Journal: PloS oneIn common: NCBI GEO GSE122063, Alzheimer's / dementia, cellular / molecular
- [4] doi:10.1038/s41598-024-54357-6
- Identification of immunogenic cell death-related genes involved in Alzheimer's disease.Journal: Scientific reportsIn common: NCBI GEO GSE122063, Alzheimer's / dementia, cellular / molecular
- [5] doi:10.1186/s12944-023-01918-9
- Identification of key lipid metabolism-related genes in Alzheimer's disease.Journal: Lipids in health and diseaseIn common: NCBI GEO GSE122063, Alzheimer's / dementia, cellular / molecular
- [6] doi:10.3389/fneur.2026.1794851
- Mitochondrial protein alterations in vascular dementia: evidence from Mendelian randomization, transcriptomics, and a chronic hypoperfusion model.Journal: Frontiers in neurologyIn common: NCBI GEO GSE122063, Alzheimer's / dementia, cellular / molecular
- [7] doi:10.1177/25424823241289804
- Identifying shared diagnostic genes and mechanisms in vascular dementia and Alzheimer's disease via bioinformatics and machine learning.Journal: Journal of Alzheimer's disease reportsIn common: NCBI GEO GSE122063, Alzheimer's / dementia, cellular / molecular
- [8] doi:10.3233/adr-240062
- Genome-Wide Mendelian Randomization Identifies Ferroptosis-Related Drug Targets for Alzheimer's Disease.Journal: Journal of Alzheimer's disease reportsIn common: NCBI GEO GSE122063, Alzheimer's / dementia, cellular / molecular
- [9] doi:10.3389/fnagi.2024.1411320
- Bioinformatics analysis of the potential receptor and therapeutic drugs for Alzheimer's disease with comorbid Parkinson's disease.Journal: Frontiers in aging neuroscienceIn common: NCBI GEO GSE122063, Alzheimer's / dementia, cellular / molecular
- [10] doi:10.3389/fnmol.2022.751044
- Identification of Molecular Signatures and Candidate Drugs in Vascular Dementia by Bioinformatics Analyses.Journal: Frontiers in molecular neuroscienceIn common: NCBI GEO GSE122063, Alzheimer's / dementia, cellular / molecular
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
